(A) Overview of study design and study groups, healthy controls (HC), PLWH in early HIV-1 infection (Ei), and PLWH on fully suppressive ART (S) in S1 and S2 time points. (B) The expression of IRs …
Epidemiological and clinical data of study groups; healthy controls (HC), PLWH in early infection (Ei), and PLWH on fully suppressive ART (S) in S1 and S2 time points.
Frequencies of IRs expression shown in pie charts as 0 to >3 IRs expressed in CD8+ T-cell subsets and study groups.
Frequencies of the 32 possible combinations of expressions for TIGIT, PD-1, LAG-3, TIM-3, and CD39 in CD8+ T-cell subsets per study group.
Frequencies of IRs expression in total and CD8+ T-cell subsets per study group.
Correlations between CD4+ T-cell counts and TIGIT+, TIGIT+TIM-3+, and combinations of IRs in total and CD8+ T-cell subsets per study group.
(A) Zebra dot plots showing the gating strategy used for the identification of total CD8+ and cellular using lineage markers (CD45RA, CCR7, and CD27) subsets as follow; naive (CD45RA+ CCR7+ CD27+), …
(A) Frequency of CD8+ T-cells and IRs expression in total CD8+ T cells across study groups (HC, Ei, S1 and S2) (B) Frequency of IRs expression in CD8+ T-cell subsets. Scatter plots represent median …
(A) Gating strategy for selecting total CD8+ T-cells (top), net-SNE plots of HC, Ei, S1, S2 and all merge groups. (B) Representative net-SNE visualization of surface markers. The colour gradient …
Unsupervised net-SNE analyses of total CD8+ T-cells.
Cluster cell frequencies from net-SNE analyses in total CD8+ T-cells per study group.
(A) Gating representation of CD107a, IFNγ and IL-2 expression in HIV-1-specific CD8+ T-cells (top), net-SNE plots of HC, Ei, S1, S2 and merge groups of SEB-activated CD8+ T-cells (bottom). (B) …
Unsupervised net-SNE analyses of SEB-activated CD8+ T-cells.
Cluster cell frequencies from net-SNE analyses of SEB-activated CD8+ T-cells per study group.
Supervised analyses of CD107a, IFNγ and IL-2 frequencies of SEB-activated CD8+ T-cells per study groups.
(A) The total frequency of CD107a, IFNγ and IL-2 SEB-activated CD8+ T-cells in HC, Ei, S1, and S2. Data represent median and interquartile ranges. (B) Table of median frequencies of CD107a, IFNγ and …
(A) Gating representation of CD107a, IFNγ, and IL-2 expression in HIV-1-specific CD8+ T-cells (top), net-SNE plots of Ei, S1, S2 and merge groups for HIV-1-specific CD8+ T-cells (bottom). (B) …
Unsupervised net-SNE analyses of HIV-1-specific CD8+ T-cells.
Cluster cell frequencies from net-SNE analyses of HIV-1-specific CD8+ Tcells per Ei and S (S1–S2) study groups.
Supervised analyses of CD107a, IFNγ and IL-2 frequencies of HIV-1-specific CD8+ T-cells in Ei and S (S1–S2) study groups.
Frequencies of CD107a, IFNγ, and IL-2 expression in TIGIT+ and TIGIT+ TIM-3+HIV-1-specific memory CD8+ T-cell subsets in Ei and S (S1–S2) study groups.
(A) Frequency of CD107a, IFNγ and IL-2 HIV-1-specific CD8+ T-cells in Ei, S1 and S2. Data represent median and interquartile ranges. (B) Table of median frequencies of CD107a, IFNγ and IL-2 …
(A) Representative flow cytometry plots gated on CD8+ T-cells, in the absence of HIV-1 Gag stimulation (basal condition) and presence of HIV-1 Gag stimulation with isotype control, αTIGIT, αTIM-3, …
Unsupervised net-SNE analyses for HIV-1-specific CD8+ T-cells in PLWH on ART.
Frequencies of CD107a, IFNγ, and IL-2 expression in total and subsets of HIV-1-specific CD8+ T-cells in PLWH on ART.
A. Graphs indicate the percentage of live cells in HIV-1 condition (Gag peptide pool) compared to HIV-1 + IgG2 isotype, HIV-1 + IgG1 isotype and HIV-1 + IgG2a+IgG1. B. Graphs indicate the % of live …
The epidemiological and clinical characteristics of the study groups.